from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1707/-

LFCtreatmentdescriptionclass of inhibitor

0.485

Amikacinug/mL Amikacintranslation

-0.482

Cap5-10ug/mL Capreomycintranslation

0.096

Rox10-50 ug/mL Roxithromycintranslation

1.064

SM2-5 ug/mL Streptomycintranslation

0.718

Tet5-10 ug/mL Tetracyclinetranslation

-0.682

Rif0.2-5ug/mL Rifampicintranscription

0.387

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.167

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.762

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.386

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.525

Clofazimine10-13 ug/mL Clofaziminerespiration

0.326

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.795

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.634

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.058

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.085

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.589

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.728

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.829

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.013

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.574

KCN5-20 ug/mL Potassium cyaniderespiration

0.161

NaN30.2-2 mM Sodium aziderespiration

1.927

Nigericin50 uM Nigericinrespiration

-0.550

TRC10-150 ug/mL Triclosanrespiration

-0.734

TRZ10-25 ug/mL Thioridazinerespiration

1.170

Valinomycin0.5-10 uM Valinomycinrespiration

2.921

ZnSO42 mM ZnSO4respiration

0.169

menadione6-10 ug/mL Menadionerespiration

0.223

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.343

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.274

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.137

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.152

NRP_1Non-replicating persistence stage 1dosRassociated

0.328

Amp0.2mg/mL AmpicillincellWall

-0.077

Cephalexin20-100 ug/mL CephalexincellWall

0.231

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.330

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.033

EMB10-20 ug/mL EthambutolcellWall

0.131

Eta12-40 ug/mL EthionamidecellWall

-0.132

INH0.2-0.4 ug/mL IsoniazidcellWall

0.207

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.735

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.389

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.388

BZA0.12 mg/mL BenzamidearomaticAmides

0.267

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.709

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.139

H2O24 mM hydrogen peroxideDNAdamaging

-0.009

Levo10 ug/mL LevofloxacinDNAdamaging

0.260

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-2.672

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.214

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.101

UVUV-irradiationDNAdamaging

-0.929

ARP41-4 ug/mL Antitubercular compound ARP4?

0.131

Antimycin12.5-50 ug/mL Antimycin A?

0.104

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.262

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.047

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.744

PA8240.2-2 ug/mL PA-824?

-1.063

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.550

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.090

Verapamil50 uM Verapamil?

0.163

mercaptoethanol2 mM 2-Mercaptoethanol?

0.589

methoxatin10-20 ug/mL Methoxatin?